With reference to the earlier intimation on March 02, 2015 about the successful completion of MHRA audit process, Bafna Pharmaceuticals Ltd has now informed BSE that the Company got the RENEWAL certificate from MHRA, London.
The stock of the company is up by 12% at Rs. 27.70.
It has hit a high of Rs. 29.40 and low of Rs. 25.25.